SERPINB4 and non-small cell lung carcinoma: Furthermore, another study demonstrated that the upregulation of SERPINB4 in NSCLC dampens NK cell-mediated cytotoxicity, suggesting potential therapeutic avenues for modulating immune responses against NSCLC (7).